US 12,246,137 B2
Catheter lock solution comprising sodium citrate and benzyl alcohol
Stephen R. Ash, Lafayette, IN (US)
Assigned to HEMOCLEANSE TECHNOLOGIES LLC, Lafayette, IN (US)
Filed by HemoCleanse Technologies LLC, Lafayette, IN (US)
Filed on Jul. 21, 2023, as Appl. No. 18/356,331.
Application 18/356,331 is a continuation of application No. 16/766,326, granted, now 11,744,983, previously published as PCT/US2018/062240, filed on Nov. 21, 2018.
Claims priority of provisional application 62/590,536, filed on Nov. 25, 2017.
Prior Publication US 2023/0364380 A1, Nov. 16, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 25/00 (2006.01); A61L 2/18 (2006.01); A61L 29/16 (2006.01); A61L 101/36 (2006.01)
CPC A61M 25/0017 (2013.01) [A61L 2/18 (2013.01); A61L 29/16 (2013.01); A61L 2101/36 (2020.08); A61M 2025/0019 (2013.01)] 25 Claims
 
1. An aqueous antimicrobial solution comprising a synergistic amount of about 6 to about 11% by weight citrate and about 1.0 to about 2.0 percent by weight benzyl alcohol dispersed or dissolved therein.